Der var ingen signifikant forskel i raten af endometriehyperplasi ved administration af kontinuerte østrogen - progestagen- kombinationer i forhold til ved administration af placebo efter 12 og 24 måneder.
There was no significant difference in the rate of endometrial hyperplasia of continuous oestrogen- progestogen combinations in comparison with placebo after 12 and 24 months.